Analysis GMO TECH, Inc. (6026)
5/27/2024
Analysis of GMO TECH, Inc. (6026)
GMO TECH, Inc. (symbol: 6026) has shown a recent uptrend in its stock price, with the price closing at 10,470 on May 27th, 2024, which is higher than the opening price of 9,600 on the same day. The Relative Strength Index (RSI) indicator of 67.31 suggests that the stock is neither overbought nor oversold.The Moving Average Convergence Divergence (MACD) indicator is at 1,229.37, with the MACD line above the signal line, indicating a bullish signal. The MACD histogram is positive at 320.39, further supporting the bullish momentum.
In terms of moving averages, the Simple Moving Average (SMA) is at 7,392.40, the Exponential Moving Average (EMA) is at 7,798.75, and the Weighted Moving Average (WMA) is at 8,023.76. The stock price is currently trading above all these moving averages, indicating a positive trend.
Overall, based on the technical indicators, GMO TECH, Inc. appears to be in a bullish phase with potential for further price appreciation. However, investors should always consider other factors such as market conditions and company fundamentals before making investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It is important to note that these are analyst estimates and actual performance may vary.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, indicating that there may be potential upside according to the analysts' predictions.
Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The book value per share is $4.837, total cash per share is $4.379, and the total debt to equity ratio is 140.968.In terms of profitability, the profit margin is 26.31% and the operating margin is 30.74%. The company has a return on assets of 22.07% and a return on equity of 147.25%. The most recent quarter ended on March 31, 2024, and the fiscal year ends on September 30, 2023.
From the income statement, we see an EBITDA of $131.39 billion, revenue of $381.62 billion, diluted EPS of 6.44, gross profit of $169.15 billion, revenue per share of $24.54, and net income to common of $100.39 billion. The quarterly revenue growth is -4.3% and the quarterly earnings growth year-over-year is -2.2%.
Moving on to stock statistics, the short ratio is 1.66, with 94.31 million shares shorted out of 1.53 billion float shares. The company has 15.31 billion shares outstanding, with 5.22% held by insiders and 57.56% held by institutions. The short percent of shares outstanding is 0.62%.
In terms of valuation metrics, the PEG ratio is 26.21, forward PE is 26.21, and trailing PE is 29.43. The enterprise value is $2.95 trillion, price to book ratio is 39.18, price to sales ratio is 7.62, enterprise to EBITDA ratio is 22.75, and enterprise to revenue ratio is 7.73. The market capitalization is $2.91 trillion.
The stock price summary shows a beta of 1.264, with a 50-day moving average of $173.69 and a 200-day moving average of $180.79. The 52-week low is $164.08, the 52-week high is $199.62, and the 52-week change is 8.25%.
Lastly, in dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The dividend date is May 16, 2024, and the ex-dividend date is May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%, while the forward annual dividend yield is 0.53% and the trailing annual dividend yield is 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a significant increase in revenue from FY 2020 to FY 2022, with a slight decrease in FY 2023.
- Overall, there has been a positive revenue growth trend over the past four years, indicating the company's ability to generate increasing sales.
- It is important to further analyze the reasons behind the fluctuations in revenue to understand the company's performance and market dynamics.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing over the years, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
MACD of 6026
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
